IntusCare key facts
as of Oct 2026- Developer of a healthcare analytics platform designed to improve care and reduce hospitalizations for socially vulnerable and clinically complex patients.
- IntusCare is valued at approximately $6.0M as of Oct 2026 (last reported valuation).
- It has raised $31.5M; the latest was Later Stage VC ($560K) in Mar 2026.
- Notable investors include Alumni Ventures, MassChallenge, Service Provider Capital, Deerfield Management, Westbound Equity Partners — 25 tracked in total.
- Status: Privately Held (backing).
IntusCare's last reported valuation, Apr 2021. Nothing priced has surfaced since.
- ·The complete investor list: 25 names
- ·Watch IntusCare: the Monday email on marks, rounds and moves
IntusCare funding rounds
No funding rounds for IntusCare are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
Who backs IntusCare
25+IntusCare valuation
IntusCare's last reported valuation was $6 million in Apr 2021. No priced round, secondary trade or fund mark has surfaced since.
IntusCare investors
25 investors are on record for IntusCare, including Alumni Ventures, MassChallenge, Service Provider Capital and Deerfield Management. By type, the record holds 5 venture capital firms, 1 angel investor and 1 private equity firm.
About IntusCare
Developer of a healthcare analytics platform designed to improve care and reduce hospitalizations for socially vulnerable and clinically complex patients. The company has created a data-driven predictive analytics platform designed for organizations such as PACE programs, nursing homes, long-term care facilities and home care agencies and helps in identifying, correlating and visualizing healthcare trends, enabling patients to get healthcare at an affordable cost.
- Sector
- Healthcare
- HQ
- Providence, RI, United States
- Founded
- 2019
- Employees
- 102
- Website
- intuscare.com/
- Ownership
- Privately Held (backing)
Is this your company? Sign in with your work email to keep it current, or tell us what's wrong.